Development and Validation of a Comprehensive Management Service Package for Older Adults With Multimorbidity
NCT ID: NCT07151430
Last Updated: 2025-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
358 participants
INTERVENTIONAL
2025-12-01
2026-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of a Healthcare Service Platform for Successful Aging
NCT06270121
Living With Multimorbidity: CO-ORDINATE Program
NCT05985044
Comprehensive Geriatric Assessment in Chronic Disease Management for Older Adults in China: A Registry Study （CGACDM - Older Adults in China）
NCT07033871
Impact Evaluation of the Digital Connect Project for Homebound Older Adults
NCT06217601
Care Transitions App for Patients With Multiple Chronic Conditions
NCT06051058
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main questions it aims to answer are:
1. Does the service package lower the number of hospital readmissions in older adults with multimorbidity?
2. Does it improve quality of life, daily function (intrinsic capacity), and treatment adherence?
3. What are the costs and potential risks of using the service package compared to usual care? Researchers will compare the service package to usual care (no service package).
Participants will:
1. Be randomly assigned to either the service package group or the usual care group
2. Use the digital tools and health management support included in the service package (such as apps, monitoring devices, and personalized health guidance)
3. Receive regular follow-up visits and surveys over 6 months to track their health, hospital use, and satisfaction
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Arm
Comprehensive multimorbidity management service package (digital tools, MDT decision support, lifestyle interventions, long-term management tools).
Service Package Group
patients receive comprehensive multimorbidity management service package (digital tools, MDT decision support, lifestyle interventions, long-term management tools).
Control Arm
Standard of care without the service package.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Service Package Group
patients receive comprehensive multimorbidity management service package (digital tools, MDT decision support, lifestyle interventions, long-term management tools).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Diagnosed with ≥2 chronic diseases or geriatric syndromes (e.g., hypertension, diabetes, frailty, depression)
3. Willing to provide informed consent
Exclusion Criteria
2. Currently participating in other clinical trials
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xuanwu Hospital, Beijing
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
yinchunlin
Director of Department of Cardiology
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023YFC3605003
Identifier Type: OTHER
Identifier Source: secondary_id
XWH-MULTICOMORB-2024-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.